1. Home
  2. DMO vs EQ Comparison

DMO vs EQ Comparison

Compare DMO & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Mortgage Opportunity Fund Inc.

DMO

Western Asset Mortgage Opportunity Fund Inc.

HOLD

Current Price

$11.01

Market Cap

127.4M

Sector

Finance

ML Signal

HOLD

EQ

Equillium Inc.

HOLD

Current Price

$2.95

Market Cap

129.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMO
EQ
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.4M
129.0M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
DMO
EQ
Price
$11.01
$2.95
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
33.7K
354.7K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.42
$0.29
52 Week High
$12.11
$3.10

Technical Indicators

Market Signals
Indicator
DMO
EQ
Relative Strength Index (RSI) 46.33 68.79
Support Level $10.91 $1.38
Resistance Level $11.16 N/A
Average True Range (ATR) 0.11 0.29
MACD -0.02 0.08
Stochastic Oscillator 23.08 88.85

Price Performance

Historical Comparison
DMO
EQ

About DMO Western Asset Mortgage Opportunity Fund Inc.

Western Asset Mortgage Defined Opportunity Fund Inc is a non-diversified, limited-term, closed-end management investment company. The fund's primary investment objective is to provide current income. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing in a diverse portfolio of mortgage-backed securities, consisting of non-agency residential mortgage-backed securities and commercial mortgage-backed securities.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: